We are live on ! Find out more
BSTC

BioSpecifics Technologies Corp.
BSTC

Delisted

BSTC was delisted on the 1st of December, 2020.

Back to rankings

107 hedge funds and large institutions have $263M invested in BioSpecifics Technologies Corp. in 2018 Q4 according to their latest regulatory filings, with 21 funds opening new positions, 31 increasing their positions, 40 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

200% more first-time investments, than exits

New positions opened: 21 | Existing positions closed: 7

15% more funds holding

Funds holding: 93 → 107 (+14)

8% more capital invested

Capital invested by funds: $244M → $263M (+$19M)

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

23% less repeat investments, than reductions

Existing positions increased: 31 | Existing positions reduced: 40

Holders
107
Holders Change
+14
Holders Change %
+15.05%
% of All Funds
2.38%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.04%
New
21
Increased
31
Reduced
40
Closed
7
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Goldman Sachs
Goldman Sachs
New York
+$5.77M
2
RHJA
Rice Hall James & Associates
California
+$4.16M
3
American Century Companies
American Century Companies
Missouri
+$1.85M
4
BlackRock
BlackRock
New York
+$1.6M
5
Assenagon Asset Management
Assenagon Asset Management
Luxembourg
+$1.43M

Top Sellers

Rank Fund Capital Flow
1
SCM
Stonepine Capital Management
Oregon
-$4.05M
2
EAM
Eagle Asset Management
Florida
-$1.7M
3
BCM
Bridgeway Capital Management
Texas
-$1.61M
4
TAM
THB Asset Management
Connecticut
-$1.19M
5
PVI
Pura Vida Investments
New York
-$1.18M
Name Holding Trade Value Shares
Change 		Change in
Stake
Royal Bank of Canada
101
Royal Bank of Canada
Ontario, Canada
$3K -$1.85K -31 -38%
DA
102
Denali Advisors
California
$3K -$1.25K -21 -30%
PNC Financial Services Group
103
PNC Financial Services Group
Pennsylvania
$2K – – –
PA
104
Parallel Advisors
California
$1K – – –
BNP Paribas Financial Markets
105
BNP Paribas Financial Markets
France
$121 -$10.6K -178 -99%
GT
106
Glenmede Trust
Pennsylvania
$59 +$58.8K +985 New
PVI
107
Pura Vida Investments
New York
– -$1.18M -20,160 Closed
Two Sigma Investments
108
Two Sigma Investments
New York
– -$1.15M -19,646 Closed
Citadel Advisors
109
Citadel Advisors
Florida
– -$340K -5,819 Closed
ZCM
110
Zebra Capital Management
Connecticut
– -$212K -3,619 Closed
AAMU
111
Amundi Asset Management US
Massachusetts
– -$135K -2,300 Closed
STA
112
Summit Trail Advisors
New York
– -$125K -2,134 Closed
Walleye Trading
113
Walleye Trading
New York
– -$26K -438 Closed
PFGIA
114
Patriot Financial Group Insurance Agency
Massachusetts
– +$179 +3 New
1 2 3 4
5

BSTC Hedge Fund Activity: Q4 2018 in Review

107 of the 4,488 institutional investors tracked by Wall St. Rank reported a position in BioSpecifics Technologies Corp. (BSTC) for Q4 2018, worth a combined $263M — up 7.8% from $244M a quarter earlier.

Buyers outnumbered sellers: 21 funds opened new BSTC positions and 7 closed out — a net gain of 14 holders — while 31 added to existing stakes and 40 trimmed.

The largest buyer was Goldman Sachs, adding an estimated $5.77M. The largest seller was Stonepine Capital Management, cutting an estimated $4.05M.

  • 107 institutional investors held BioSpecifics Technologies Corp. (BSTC) as of Q4 2018, up from 93 in Q3 2018.
  • Funds reported $263M of BioSpecifics Technologies Corp. stock for Q4 2018, up 7.8% quarter-over-quarter.
  • 21 funds opened new BioSpecifics Technologies Corp. positions in Q4 2018 and 7 closed out, a net change of +14 holders.
  • The largest BioSpecifics Technologies Corp. buyer in Q4 2018 was Goldman Sachs, an estimated $5.77M added.
  • The largest BioSpecifics Technologies Corp. seller in Q4 2018 was Stonepine Capital Management, an estimated $4.05M sold.

Based on aggregated 13F filings for Q4 2018.